Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers.

Saved in:
Bibliographic Details
Title: Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers.
Authors: Lane RM; Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. rlane@ionisph.com., Darreh-Shori T; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Clinical Geriatric, Karolinska Institutet, Stockholm, Sweden., Junge C; Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA, 92010, USA., Li D; Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA, 92010, USA., Yang Q; Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA, 92010, USA., Edwards AL; Biogen, Cambridge, MA, USA., Graham DL; Biogen, Cambridge, MA, USA., Moore K; Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA, 92010, USA., Mummery CJ; Dementia Research Centre, Institute of Neurology, London, UK.
Source: BMC neurology [BMC Neurol] 2024 Apr 09; Vol. 24 (1), pp. 116. Date of Electronic Publication: 2024 Apr 09.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377 (Electronic) Linking ISSN: 14712377 NLM ISO Abbreviation: BMC Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2377
DOI:10.1186/s12883-024-03611-5